RNA Earnings Atrium Therapeutics, Inc.

Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →

1–2 of 2


Q1 2026	2026-03-31	-0.97	2026-05-14	10-Q
Q1 2026	2025-03-31	-0.44	2026-05-14	10-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.